REFERENCES

Agarwal, A., Mulgund, A., Hamada, A., & Chyatte, M. R. (2015). A new version of
the sperm morphology normal reference values based on strict criteria and its effect
on the clinical diagnosis of teratozoospermia. Andrology, 3(3), 427-435.

Basile, J. P., & Devarajan, P. (2017). Cisplatin nephrotoxicity: Mechanisms and

prevention strategies. Nephrology Reviews, 7(1), 33-40.

Chabner, B. A., & Longo, D. L. (Eds.). (2014). Harrison's principles of internal

medicine (19th ed.). McGraw-Hill Education.

Chinsembu, K. C. (2016). Herbal medicine in the management of male infertility: A

review. Andrology, 4(4), 607-619.

Devarajan, P., & Parikh, C. R. (2009). Cisplatin-induced nephrotoxicity: Mechanisms

and renoprotective strategies. Kidney International, 76(6), 604-616.

Einbom, A. (1990). Testicular cancer: Diagnosis and treatment. BMJ, 300(6722),

591-594.

Ferguson, M. A., Simmons, N. L., & Knepper, M. A. (2008). The roles of aquaporins
in kidney physiology. News in Physiological Sciences, 23(4), 259-264.

Finn, P. W., & Porter, G. A. (Eds.). (2003). Adverse drug reactions: A practical guide
to diagnosis and management (2nd ed.). Wiley.

Galley, H. F. (2000). Oxidative stress and inflammation in genetic and environmental

kidney disease. Current Opinion in Nephrology and Hypertension, 9(3), 299-305.

Galluzzi, L., Vitale, I., Aaronson, S. A., & Kroemer, G. (2018). Cisplatin-induced
cardiotoxicity: mechanisms of damage and strategies for cardioprotection. Chemical
Reviews, 118(23), 12333-12371.

Gullo, F., De Sio, I., Di Martino, M., & Cozza, D. (2020). Cisplatin-induced
nephrotoxicity: A review of the potential protective strategies. Anti-Cancer Agents in
Medicinal Chemistry, 20(18), 2191-2201.

Kohli, H. S., Agarwal, S. K., & Chawla, R. (2000). Cisplatin-induced nephrotoxicity:

A review. Indian Journal of Pharmacology, 32(4), 273.
Levey, A. S., Stevens, L. A., & Coresh, J. (2009). The definition, classification, and
diagnosis of chronic kidney disease: A position statement from Kidney Disease:
Improving Global Outcomes (KDIGO). Kidney International, 76(supplément 1), S1-
S30.

Levine, H., Jørgensen, N., Martino-Andrade, A., Mendiola, J., Weksler-Derri, D.,
Mindlis, I., & Swan, S. H. (2017). Temporal trends in sperm count: a systematic
review and meta-regression analysis. Human Reproduction Update, 23(6), 646-659.

Miller, R. P., Tadagavadi, R. K., Ramesh, G., & Reeves, W. B. (2010). Mechanisms
of cisplatin nephrotoxicity. Toxins, 2(11), 2490-2518.

Nagai, T., & Takano, M. (2010). Cisplatin-induced nephrotoxicity: Molecular

mechanisms and antidotes. Kidney International, 77(3), 217-226.

Naughton, C. A. (2008). Cisplatin nephrotoxicity. In Current Topics in Oncology (pp.

25-35). Springer, Berlin, Heidelberg.

Pabla, N., & Dong, Z. (2008). Cisplatin nephrotoxicity: Mechanisms and strategies
for prevention. Kidney International